It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Astrocytes play a key role in the regulation of synaptic strength and are thought to orchestrate synaptic plasticity and memory. Yet, how specifically astrocytes and their neuroactive transmitters control learning and memory is currently an open question. Recent experiments have uncovered an astrocyte-mediated feedback loop in CA1 pyramidal neurons which is started by the release of endocannabinoids by active neurons and closed by astrocytic regulation of the D-serine levels at the dendrites. D-serine is a co-agonist for the NMDA receptor regulating the strength and direction of synaptic plasticity. Activity-dependent D-serine release mediated by astrocytes is therefore a candidate for mediating between long-term synaptic depression (LTD) and potentiation (LTP) during learning. Here, we show that the mathematical description of this mechanism leads to a biophysical model of synaptic plasticity consistent with the phenomenological model known as the BCM model. The resulting mathematical framework can explain the learning deficit observed in mice upon disruption of the D-serine regulatory mechanism. It shows that D-serine enhances plasticity during reversal learning, ensuring fast responses to changes in the external environment. The model provides new testable predictions about the learning process, driving our understanding of the functional role of neuron-glia interaction in learning.
A biophysical model, based on astrocyte-mediated feedback in CA1 neurons, aligns with the BCM model, explaining learning deficits in mice when D-serine regulation is disrupted
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 University of Bonn, Institute of Experimental Epileptology and Cognition Research, Medical Faculty, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300)
2 Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan (GRID:grid.250464.1) (ISNI:0000 0000 9805 2626)
3 University of Bonn, Institute of Cellular Neurosciences, Medical Faculty, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300)
4 University of Bonn, Institute of Cellular Neurosciences, Medical Faculty, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300); German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426)